5299 篇
13868 篇
408774 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)
Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.
CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW
CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW